Showing results (681-690 of 9,668) with videos related to

Sort By:
Pageof 967
Leukemia|May 19, 2021
MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistanceJordy C G van der Zwet, Jessica G C A M Buijs-Gladdines, Valentina Cordo', et al.
Leukemia|May 21, 2021
Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 studyFrancisco Cervantes, David M Ross, Atanas Radinoff, et al.
Leukemia|May 23, 2021
Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMTNicolaus Kröger, Giulia Sbianchi, Tiarlan Sirait, et al.
Leukemia|May 22, 2021
CD137 (4-1BB) stimulation leads to metabolic and functional reprogramming of human monocytes/macrophages enhancing their tumoricidal activityA Stoll, H Bruns, M Fuchs, et al.
Leukemia|May 22, 2021
The balance between the intronic miR-342 and its host gene Evl determines hematopoietic cell fate decisionFriederike Herbst, Tonio J L Lang, Elias S P Eckert, et al.
Leukemia|May 22, 2021
JAK2 unmutated erythrocytosis: current diagnostic approach and therapeutic viewsNaseema Gangat, Natasha Szuber, Animesh Pardanani, et al.
Leukemia|May 12, 2021
Enhanced differentiation of functional human T cells in NSGW41 mice with tissue-specific expression of human interleukin-7Emilie Coppin, Bala Sai Sundarasetty, Susann Rahmig, et al.
Leukemia|May 29, 2020
Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 yearsAnn-Kathrin Eisfeld, Jessica Kohlschmidt, Alice Mims, et al.
Leukemia|February 4, 2023
Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemiaClement Larrue, Sarah Mouche, Shan Lin, et al.
Leukemia|July 10, 1999
Quantitative competitive reverse transcriptase-polymerase chain reaction for BCR-ABL on Philadelphia-negative leukaphereses allows the selection of low-contaminated peripheral blood progenitor cells for autografting in chronic myelogenous leukemiaM T Corsetti, E Lerma, A Dejana, et al.
Pageof 967